TD ASSET MANAGEMENT INC - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 107 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,626,206
+25.3%
180,768
+76.1%
0.00%
+33.3%
Q2 2023$2,895,136
+103.5%
102,628
+24.1%
0.00%
+50.0%
Q1 2023$1,422,560
-14.6%
82,7070.0%0.00%0.0%
Q4 2022$1,665,719
-6.3%
82,7070.0%0.00%0.0%
Q3 2022$1,777,000
-23.4%
82,707
+0.1%
0.00%
-33.3%
Q2 2022$2,321,000
-52.5%
82,607
-22.0%
0.00%
-25.0%
Q1 2022$4,886,000
-50.6%
105,903
-10.0%
0.00%
-50.0%
Q4 2021$9,888,000
+62.6%
117,633
+28.9%
0.01%
+33.3%
Q3 2021$6,081,000
+39.4%
91,258
+11.3%
0.01%
+50.0%
Q2 2021$4,361,000
+243.9%
81,966
+180.6%
0.00%
+300.0%
Q1 2021$1,268,000
-0.3%
29,215
+19.3%
0.00%
-50.0%
Q4 2020$1,272,000
+73.1%
24,493
+8.9%
0.00%
+100.0%
Q3 2020$735,000
-31.9%
22,4930.0%0.00%
-50.0%
Q2 2020$1,080,00022,4930.00%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 1,824,583$39,520,00014.33%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,301,771$49,857,0004.79%
Matrix Capital Management Company, LP 9,199,973$199,271,0003.81%
Integral Health Asset Management, LLC 550,000$11,913,0002.31%
Avidity Partners Management LP 4,223,100$91,472,0001.86%
Affinity Asset Advisors, LLC 170,000$3,682,0001.03%
Eventide Asset Management 1,861,000$40,309,0000.79%
Sofinnova Investments, Inc. 583,357$12,636,0000.74%
Nicholas Investment Partners, LP 158,704$3,438,0000.32%
SECTORAL ASSET MANAGEMENT INC 60,000$1,300,0000.26%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders